Article
Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials
2 Jan 2020
Abstract excerpt
Telomeres are protective chromosomal ends that shield the chromosomes from DNA damage, exonucleolytic degradation, recombination, and end-to-end fusion. Telomerase is a ribonucleoprotein that adds TTAGGG tandem repeats to the telomeric ends. It has been observed that 85 to 90% of human tumors express high levels of telomerase, playing a crucial role in the development of cancers. Interestingly, the telomerase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
